Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


INTESTINAL PERFORATION side effect

What is INTESTINAL PERFORATION ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   INTESTINAL PERFORATION and Recently Reported Side Effects   INTESTINAL PERFORATION and 15 most Active Side Effect polls   INTESTINAL PERFORATION and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with INTESTINAL PERFORATION

ABILIFY  ALEVE  APTIVUS  ARIMIDEX  ASPIRIN  AVASTIN  AVONEX  BETASERON  BEVACIZUMAB  CAPECITABINE  CELEBREX  CETUXIMAB  CISPLATIN  CLARITHROMYCIN  CLOZAPINE  COMTAN  COPAXONE  CYTARABINE  CYTOXAN  DIANEAL  DIAZEPAM  DICLOFENAC  DICYCLOMINE  DOCETAXEL  DOXIL  DOXORUBICIN  EFFEXOR  ENBREL  ERBITUX  ERLOTINIB  EXTRANEAL  FENTANYL  FLEBOGAMMA  FLUOROURACIL  FORTEO  FRISIUM  GEMCITABINE  GEMZAR  GOODY  HALDOL  HEPARIN  HERCEPTIN  HUMALOG  HUMATROPE  HUMIRA  HYCAMTIN  IBUPROFEN  IMODIUM  INDOCIN  INDOMETHACIN  INFLIXIMAB  IPILIMUMAB  IRINOTECAN  ISOVORIN  LAMICTAL  LAPATINIBLET  LEVOTHYROXINE  LIORESAL  LORAZEPAM  MABTHERA  MEDROL  MELOXICAM  MIRENA  NATALIZUMAB  NEOPROFEN  NEXAVAR  NITRIC  NOXAFIL  OPANA  ORENCIA  OXYCODONE  PACLITAXEL  PANITUMUMAB  PARAPLATIN  PAZOPANIB  PEMETREXED  PRILOSEC  PROGRAF  REBIF  REMICADE  RITUXAN  RITUXIMAB  SANDIMMUNE  SEROQUEL  SORAFENIB  SUNITINIB  SUTENT  SYNAGIS  TARCEVA  TAXOTERE  TEMSIROLIMUS  TIPRANAVIR  TYKERB  WARFARIN  ZAVESCA  ZEMPLAR  


Panitumumab Side Effects Report #5657171-9
Physician from UNITED KINGDOM reported PANITUMUMAB problem on Feb 26, 2008. Male patient, weighting 185.2 lb, was diagnosed with colorectal cancer and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . PANITUMUMAB dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Nitric Side Effects Report #5657948-X
NITRIC OXIDE problem was reported by a Physician from GERMANY on Feb 17, 2008. Male patient, weighting 1.32 lb, was diagnosed with lung disorder, prophylaxis and was treated with NITRIC OXIDE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, no therapeutic response, patent ductus arteriosus, . NITRIC OXIDE dosage: unknown. During the same period patient was treated with NITRIC OXIDE, FLUTICASONE, ALBUTEROL, IPRATROPIUM BROMIDE, INDOMETHACIN. Patient recovered.

Dianeal Side Effects Report #5663254-X
Health Professional from UNITED STATES reported DIANEAL problem on Mar 04, 2008. Female patient, 73 years of age, was diagnosed with peritoneal dialysis and was treated with DIANEAL. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . DIANEAL dosage: unknown. During the same period patient was treated with EPOGEN, DIPROLENE, TYLENOL, VICODIN, VITAMIN CAP, LIPITOR, PLAVIX. Patient was hospitalized. Patient recovered.

Arimidex Side Effects Report #5663318-0
ARIMIDEX problem was reported by a Consumer or non-health professional from BRAZIL on Mar 06, 2008. Female patient, 69 years of age, was diagnosed with breast cancer, diabetes mellitus, hypertension, prophylaxis and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, metastases to gastrointestinal tract, . ARIMIDEX dosage: unknown. During the same period patient was treated with INSULIN, MALEATO DE ENALAPRIL, GILFAGE, FOSAMAX. Patient was hospitalized. Patient died on 02/01/2007.


Tarceva Side Effects Report #5664278-9
Physician from UNITED STATES reported TARCEVA problem on Feb 27, 2008. Female patient, 73 years of age, was diagnosed with bronchioloalveolar carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, pneumonitis, . TARCEVA dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient died.

Orencia Side Effects Report #5669224-X
ORENCIA problem was reported by a Physician from CANADA on Mar 05, 2008. Female patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with ORENCIA. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, mouth cyst, oral disorder, peritonitis, tooth abscess, . ORENCIA dosage: unknown. During the same period patient was treated with CELEBREX, PREVACID, GABAPENTIN, ALPRAZOLAM, EFFEXOR, ZOPICLONE, TYLENOL, DIDROCAL. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5679151-X
Physician from UNITED STATES reported CAPECITABINE problem on Mar 21, 2008. Male patient, weighting 170.0 lb, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . CAPECITABINE dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient died on 03/04/2008.

Mirena Side Effects Report #5686644-8
MIRENA problem was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Female patient, 37 years of age, weighting 143.3 lb, was diagnosed with contraception and was treated with MIRENA. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, uterine rupture, . MIRENA dosage: unknown. During the same period patient was treated with VITAMIN. Patient was hospitalized. Patient recovered.

Mirena Side Effects Report #5687665-1
Health Professional from UNITED STATES reported MIRENA problem on Feb 27, 2007. Female patient, 19 years of age, weighting 145.5 lb, was treated with MIRENA. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, uterine rupture, . MIRENA dosage: unknown. Patient recovered.


Humira Side Effects Report #5613023-1
HUMIRA problem was reported by a Physician from UNITED STATES on Jan 28, 2008. Female patient, weighting 240.3 lb, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . HUMIRA dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, ALPRAZOLAM, PANTOPRAZOLE, VICODIN, FLUCONAZOLE, MESALAMINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5619986-2
Health Professional from UNITED STATES reported CAPECITABINE problem on Feb 01, 2008. Female patient, 67 years of age, weighting 101.4 lb, was diagnosed with pancreatic carcinoma and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . CAPECITABINE dosage: unknown. Patient was hospitalized. Patient died on 01/23/2008.

Nexavar Side Effects Report #5624273-2
NEXAVAR problem was reported by a Physician from ITALY on Feb 07, 2008. Male patient, 65 years of age, was diagnosed with renal cell carcinoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, peritonitis, . NEXAVAR dosage: TOTAL DAILY DOSE: 200 MG. During the same period patient was treated with DEXAMETHASONE, MORPHINE CHLORHYDRATE, LIMICAN. Patient was hospitalized. Patient recovered.

Sutent Side Effects Report #5631063-3
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Feb 12, 2008. Male patient, weighting 138.0 lb, was diagnosed with malignant melanoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . SUTENT dosage: unknown. During the same period patient was treated with NORCO, TOPROL, AVODART, CYMBALTA, NEXIUM, LYRICA, FOLIC ACID, ZOCOR. Patient died on 01/01/2008.

Enbrel Side Effects Report #5631902-6
ENBREL problem was reported by a Health Professional from GERMANY on Feb 08, 2008. Female patient, weighting 176.4 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, pancreatitis necrotising, peritoneal infection, . ENBREL dosage: unknown. Patient was hospitalized. Patient died on 10/01/2007.


Taxotere Side Effects Report #5637289-7
Health Professional from UNITED STATES reported TAXOTERE problem on Feb 15, 2008. Female patient, 70 years of age, weighting 130.1 lb, was diagnosed with pain and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, kidney infection, . TAXOTERE dosage: unknown. During the same period patient was treated with LONAFARNIB, PERCOCET, LOMOTIL, LOVENOX, LASIX, MAGNESIUM OXIDE, REGLAN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient died on 01/31/2008.

Capecitabine Side Effects Report #5638876-2
CAPECITABINE problem was reported by a Health Professional from UNITED STATES on Feb 18, 2008. Female patient, 67 years of age, weighting 101.4 lb, was diagnosed with pancreatic carcinoma and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . CAPECITABINE dosage: unknown. Patient was hospitalized. Patient died on 01/23/2008.

Mabthera Side Effects Report #5582097-9
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on Dec 27, 2007. Male patient, weighting 205.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, metabolic acidosis, . MABTHERA dosage: 50 MG, UNK. During the same period patient was treated with CLEMASTINE FUMARATE, DEXAMETHASONE, MITOXANTRONE. Patient died on 12/24/2007.

Erbitux Side Effects Report #5583092-6
ERBITUX problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2008. Male patient was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . ERBITUX dosage: unknown. Patient was hospitalized. Patient recovered.

Nexavar Side Effects Report #5588238-1
Pharmacist from UNITED STATES reported NEXAVAR problem on Jan 09, 2008. Male patient, 65 years of age, weighting 233.7 lb, was diagnosed with renal cell carcinoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, peritonitis, . NEXAVAR dosage: 400MG BID INJ. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5593700-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 10, 2008. Female patient, weighting 125.0 lb, was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, MOTRIN, DARVOCET, VYTORIN, XANAX. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5596021-6
Physician from UNITED KINGDOM reported CAPECITABINE problem on Jan 14, 2008. Male patient, 72 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CLEXANE. Patient was hospitalized. Patient died on 07/18/2007.

Temsirolimus Side Effects Report #5597178-3
TEMSIROLIMUS problem was reported by a Physician from KOREA, REPUBLIC OF on Jan 09, 2008. Male patient, weighting 143.3 lb, was diagnosed with renal cell carcinoma, skin reaction, constipation, pelvic pain, prophylaxis and was treated with TEMSIROLIMUS. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, peritonitis, . TEMSIROLIMUS dosage: unknown. During the same period patient was treated with NAPROXEN, ACYCLOVIR, MAGNESIUM OXIDE, MUPIROCIN, OXYCODONE HYDROCHLORIDE, REBAMIPIDE. Patient was hospitalized. Patient recovered.

Doxil Side Effects Report #5604392-7
Health Professional from UNITED STATES reported DOXIL problem on Jan 18, 2008. Female patient, 32 years of age, was diagnosed with ovarian cancer and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . DOXIL dosage: unknown. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5604406-4
REMICADE problem was reported by a Physician from UNITED KINGDOM on Jan 22, 2008. Female patient, 60 years of age, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, t-cell lymphoma, . REMICADE dosage: unknown. Patient recovered.

Copaxone Side Effects Report #5634132-7
Consumer or non-health professional from UNITED STATES reported COPAXONE problem on July 26, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, multiple sclerosis relapse, . COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient recovered.

Capecitabine Side Effects Report #5553875-7
CAPECITABINE problem was reported by a Physician from AUSTRALIA on Dec 05, 2007. Female patient, 47 years of age, weighting 202.8 lb, was diagnosed with hypertension, pain and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, small intestinal obstruction, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, LIPITOR, OXYCONTIN, ENDONE, PARACETAMOL. Patient was hospitalized. Patient recovered.

Copaxone Side Effects Report #5554923-0
Physician from UNITED STATES reported COPAXONE problem on Nov 29, 2007. Female patient was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, sepsis, . COPAXONE dosage: (20 MG), SUBCUTANEOUS. Patient died.

Avastin Side Effects Report #5571142-2
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Dec 10, 2007. Female patient, weighting 160.9 lb, was diagnosed with breast cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, multi-organ failure, peritonitis, . AVASTIN dosage: 730 MG, Q3W. During the same period patient was treated with NAVELBINE, AREDIA. Patient was hospitalized. Patient died on 10/18/2007.

Ibuprofen Side Effects Report #5506569-8
Consumer or non-health professional from UNITED STATES reported IBUPROFEN problem on Oct 05, 2007. Male patient was diagnosed with analgesia and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . IBUPROFEN dosage: unknown. Patient recovered.

Ibuprofen Side Effects Report #5506571-6
IBUPROFEN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2007. Female patient was diagnosed with analgesia and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . IBUPROFEN dosage: unknown. Patient recovered.

Bevacizumab Side Effects Report #5508983-3
Physician from UNITED STATES reported BEVACIZUMAB problem on Nov 01, 2007. Female patient, weighting 125.0 lb, was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, MOTRIN, DARVOCET, VYTORIN, XANAX. Patient was hospitalized. Patient recovered.

Hycamtin Side Effects Report #5510782-3
HYCAMTIN problem was reported by a Pharmacist from JAPAN on Nov 01, 2007. Male patient, 71 years of age, was treated with HYCAMTIN. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, pyrexia, vomiting, . HYCAMTIN dosage: 1.6MG PER DAY. During the same period patient was treated with LANSOPRAZOLE, ALLOPURINOL, MAGNESIUM OXIDE, DICLOFENAC, OXYCODONE HYDROCHLORIDE, FAROPENEM, OXYCODONE HYDROCHLORIDE, PICOSULPHATE. Patient was hospitalized. Patient recovered.

Humira Side Effects Report #5513322-8
Health Professional from UNITED STATES reported HUMIRA problem on Nov 02, 2007. Male patient, weighting 159.1 lb, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, rash, rash pruritic, skin exfoliation, . HUMIRA dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN, FOLIC ACID. Patient was hospitalized. Patient recovered.

Cytoxan Side Effects Report #5519058-1
CYTOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 12, 2007. Female patient, 42 years of age, weighting 180.8 lb, was treated with CYTOXAN. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . CYTOXAN dosage: unknown. Patient was hospitalized. Patient recovered.

Ibuprofen Side Effects Report #5526508-3
Pharmacist from UNITED STATES reported IBUPROFEN LYSINE problem on Nov 21, 2007. Male patient, weighting 3.31 lb, was diagnosed with ductus arteriosus premature closure and was treated with IBUPROFEN LYSINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, lung disorder, . IBUPROFEN LYSINE dosage: 7.3 MG ONCE IV; 9 MG Q24H; IV. During the same period patient was treated with IBUPROFEN LYSINE. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5529756-1
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2007. Male patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, sepsis, . AVONEX dosage: unknown. Patient was hospitalized. Patient died on 10/24/2005.

Neoprofen Side Effects Report #5530281-2
Pharmacist from UNITED STATES reported NEOPROFEN problem on Nov 27, 2007. Female patient, weighting 1.74 lb, was diagnosed with patent ductus arteriosus and was treated with NEOPROFEN. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, sepsis, . NEOPROFEN dosage: 8.57 MG DAILY IV; 3.8 MG DAILY IV. During the same period patient was treated with GENTAMICIN, AMPICILLIN. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5473228-X
CAPECITABINE problem was reported by a Physician from UNITED KINGDOM on Sept 19, 2007. Male patient, 72 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, ENOXAPARIN. Patient was hospitalized. Patient died on 07/18/2007.

Capecitabine Side Effects Report #5490827-X
Physician from UNITED KINGDOM reported CAPECITABINE problem on Oct 10, 2007. Male patient, 72 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, procedural complication, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CLEXANE. Patient was hospitalized. Patient died on 07/18/2007.

Betaseron Side Effects Report #5503304-4
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2007. Female patient, 51 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . BETASERON dosage: unknown. Patient was hospitalized. Patient died on 09/04/2007.

Erlotinib Side Effects Report #5504558-0
Physician from CANADA reported ERLOTINIB problem on Oct 16, 2007. Male patient, 51 years of age, weighting 138.2 lb, was diagnosed with pancreatic carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, renal failure, . ERLOTINIB dosage: 150 MG QD ORAL. During the same period patient was treated with OXYCONTIN, OXYCODONE, CREON, SENOKOT, COLACE. Patient was hospitalized. Patient recovered.

Betaseron Side Effects Report #5468910-4
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2007. Male patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Nexavar Side Effects Report #5405596-9
Physician from UNITED STATES reported NEXAVAR problem on Aug 02, 2007. Male patient, 58 years of age, was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, metastatic renal cell carcinoma, multi-organ failure, peritonitis, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient died on 01/15/2007.

Doxorubicin Side Effects Report #5408226-5
DOXORUBICIN HYDROCHLORIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2007. Female patient, weighting 147.7 lb, was treated with DOXORUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, mental status changes, multi-organ failure, pneumonia, post procedural complication, renal failure, respiratory distress, respiratory failure, sepsis, . DOXORUBICIN HYDROCHLORIDE dosage: 54 MG. During the same period patient was treated with ETOPOSIDE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5408251-4
Pharmacist from GERMANY reported AVONEX problem on July 25, 2007. Male patient, 63 years of age, weighting 167.6 lb, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, peritonitis, pneumonia, weight decreased, . AVONEX dosage: unknown. During the same period patient was treated with MONOFLAM, NOVAMIN. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5412821-7
PROGRAF problem was reported by a Physician from UNITED STATES on Aug 01, 2007. Male patient, 50 years of age, was diagnosed with kidney transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . PROGRAF dosage: 3 MG, BID. Patient was hospitalized. Patient died on 07/11/2007.

Capecitabine Side Effects Report #5379046-5
Physician from UNITED KINGDOM reported CAPECITABINE problem on June 22, 2007. Male patient, 72 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Pazopanib Side Effects Report #5384175-6
PAZOPANIB problem was reported by a Physician from ITALY on July 04, 2007. Female patient, 44 years of age, weighting 92.59 lb, was treated with PAZOPANIB. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, syncope, . PAZOPANIB dosage: 400MG PER DAY. During the same period patient was treated with LAPATINIB, TORADOL. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5388435-4
Physician from UNITED KINGDOM reported CAPECITABINE problem on July 06, 2007. Male patient, 72 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5445174-9
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, skin reaction, . RITUXAN dosage: 375 MG/M2, INTRAVENOUS. During the same period patient was treated with MAGNESIUM SULPHATE. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5379046-5
Physician from UNITED KINGDOM reported CAPECITABINE problem on June 22, 2007. Male patient, 72 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about INTESTINAL PERFORATION side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about INTESTINAL PERFORATION